Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kimitoshi Nakamura, Murray Robertson, Gang Liu, Peter Dickie, Kyoko Nakamura, Ji Qing Guo, Henry J. Duff, Michal Opas, Katherine Kavanagh, Marek Michalak
Published in Volume 107, Issue 10
J Clin Invest. 2001; 107(10):1245–1253 doi:10.1172/JCI12412
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Pathological changes in calreticulin transgenic mice. (a and b) Gross morphology of control and transgenic 7-day-old mouse hearts, respectively. No significant morphological changes are observed. (c–f) Gross morphology of transgenic and control 14-day-old mouse hearts (line M148). (c and d) Transverse sections. (e and f) Sagittal sections. (g and h) High magnification images of control and transgenic 14-day-old mouse hearts stained with H&E. (i–l) Sections of transgenic and control (wild-type) cardiac tissue were immunostained with anti-calreticulin (anti-CRT) (i and j) or anti-calsequestrin (anti-CSQ) (k and l) antibodies.